JAK Inhibitors
JAK inhibitors are immunosuppressive drugs that block Janus kinase signaling, interrupting cytokine pathways involved in inflammation and immune activation. They are used for autoimmune and inflammatory diseases such as rheumatoid arthritis and ulcerative colitis, where they can reduce symptoms and tissue damage but also raise infection and clotting risks.
Interactions
Supplement interactions on fileNo supplement in this library is recorded as interacting with this medication. Coverage is partial — 171 of 216 medications have interaction data, drawn from the 107 supplements written up so far. Absence here is incomplete coverage, not a safety claim.
- Trade names
- Tofacitinib (Xeljanz), Baricitinib (Olumiant), Upadacitinib (Rinvoq)
- family
- immunosuppressants